An Act to reduce co-pays for people with chronic conditions
This bill creates a state-run program to lower out-of-pocket costs for Massachusetts residents with specific chronic conditions like diabetes, asthma, and heart disease. It mandates that the state select one generic and one brand-name medication for each condition based on clinical evidence, cost-effectiveness, and safety. Under the new rules, these selected drugs would be covered with reduced co-pays for eligible patients. The legislation also explicitly designates insulin as the covered medication for diabetes.
Bill status
passed
3 of 4 stages cleared
Introduction
Feb 2023
Committee Review
Feb 2024
Senate Passage
Feb 2023
Governor
Introduced Feb 16, 2023
Last action May 9, 2024
Floor votes
How they voted
This bill passed the Senate. No roll call record of that vote is available.
Full legislative history
Actions timeline
Total actions
5
Key actions
1
Committee
2
Feb 22, 2024
Committee
Reported favorably by committee and referred to the committee on Health Care Financing
lower
Feb 16, 2023
Upper · Passed
Senate concurred
upper
Feb 16, 2023
Committee
Referred to the committee on Financial Services
lower
0 primary · 20 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about H 943
Scope: MA
Hi! I can help you understand H 943. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline